Education
About Us
Working with TipRanks
Follow Us
Voyager Therapeutics (VYGR)
NASDAQ:VYGR
VYGR Analyst Ratings
Strong Buy
8 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
VYGR Stock 12 Month Forecast
Average Price Target
$14.71
▲(364.04% Upside)
| Highest Price Target$30.00 | Average Price Target$14.71 | Lowest Price Target$9.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TD Cowen
Reiterated
04/08/25
Wells Fargo
Reiterated
04/08/25
H.C. Wainwright
Reiterated
04/07/25
Citi
Reiterated
03/13/25
Truist Financial
Reiterated
03/12/25
Canaccord Genuity
Reiterated
03/12/25
Wedbush
Reiterated
03/12/25
Leerink Partners
Reiterated
03/12/25
Oppenheimer
$18
Buy
467.82%
Upside
Reiterated
01/14/25
Oppenheimer Sticks to Its Buy Rating for Voyager Therapeutics (VYGR)
Cantor Fitzgerald
―
Buy
―
Initiated
01/10/25
Cantor Fitzgerald starts Voyager Therapeutics (VYGR) at OverweightCantor Fitzgerald analyst Pete Stavropoulos initiates coverage on Voyager Therapeutics (NASDAQ: VYGR) with a Overweight rating.
Robert W. Baird
$18
Buy
467.82%
Upside
Reiterated
11/12/24
Promising Developments and Financial Stability Bolster Buy Rating for Voyager Therapeutics
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TD Cowen
Reiterated
04/08/25
Wells Fargo
Reiterated
04/08/25
H.C. Wainwright
Reiterated
04/07/25
Citi
Reiterated
03/13/25
Truist Financial
Reiterated
03/12/25
Canaccord Genuity
Reiterated
03/12/25
Wedbush
Reiterated
03/12/25
Leerink Partners
Reiterated
03/12/25
Oppenheimer
$18
Buy
467.82%
Upside
Reiterated
01/14/25
Oppenheimer Sticks to Its Buy Rating for Voyager Therapeutics (VYGR)
Cantor Fitzgerald
―
Buy
―
Initiated
01/10/25
Cantor Fitzgerald starts Voyager Therapeutics (VYGR) at OverweightCantor Fitzgerald analyst Pete Stavropoulos initiates coverage on Voyager Therapeutics (NASDAQ: VYGR) with a Overweight rating.
Robert W. Baird
$18
Buy
467.82%
Upside
Reiterated
11/12/24
Promising Developments and Financial Stability Bolster Buy Rating for Voyager Therapeutics
Best Analysts Covering Voyager Therapeutics
Which Analyst Should I Follow If I Want to Buy VYGR and Sell After:
1 Month
xxx
Success Rate
6/10 ratings generated profit
Average Return
+2.29%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +2.29% per trade.
3 Months
xxx
Success Rate
7/20 ratings generated profit
Average Return
-6.37%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 35.00% of your transactions generating a profit, with an average return of -6.37% per trade.
1 Year
Success Rate
9/20 ratings generated profit
Average Return
-6.88%
reiterated a buy rating 5 months ago
Copying Jack Allen's trades and holding each position for 1 Year would result in 45.00% of your transactions generating a profit, with an average return of -6.88% per trade.
2 Years
xxx
Success Rate
7/20 ratings generated profit
Average Return
-23.39%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 35.00% of your transactions generating a profit, with an average return of -23.39% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
VYGR Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
12
10
5
14
14
Buy
7
5
2
3
3
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
19
15
7
17
17
Each month's total comprises the sum of three months' worth of ratings.
VYGR Financial Forecast
VYGR Stock Forecast FAQ
What is VYGR’s average 12-month price target, according to analysts?
Based on analyst ratings, Voyager Therapeutics’s 12-month average price target is $14.71.
What is VYGR’s upside potential, based on the analysts’ average price target?
Voyager Therapeutics has 364.04% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is VYGR a Buy, Sell or Hold?
Voyager Therapeutics has a consensus rating of Strong Buy which is based on 8 buy ratings, 0 hold ratings and 0 sell ratings.
What is Voyager Therapeutics’s price target?
The average price target for Voyager Therapeutics is $14.71. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $30.00 ,the lowest forecast is $9.00. The average price target represents 364.04% Increase from the current price of $3.17.
The highest analyst price target is $30.00 ,the lowest forecast is $9.00. The average price target represents 364.04% Increase from the current price of $3.17.
What do analysts say about Voyager Therapeutics?
Voyager Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of VYGR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.